Cargando…
Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
OBJECTIVE: Patients with type 1 diabetes (T1D) with impaired renal function are at increased risk for end-stage renal disease (ESRD). Although the rate of progression varies, determinants and mechanisms of this variation are unknown. RESEARCH DESIGN AND METHODS: We examined serum metabolomic profile...
Autores principales: | Niewczas, Monika A., Mathew, Anna V., Croall, Stephanie, Byun, Jaeman, Major, Melissa, Sabisetti, Venkatta S., Smiles, Adam, Bonventre, Joseph V., Pennathur, Subramaniam, Krolewski, Andrzej S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319475/ https://www.ncbi.nlm.nih.gov/pubmed/28087576 http://dx.doi.org/10.2337/dc16-0173 |
Ejemplares similares
-
Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes
por: Pezzolesi, Marcus G., et al.
Publicado: (2015) -
Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria
por: Krolewski, Andrzej S., et al.
Publicado: (2014) -
Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria
por: Skupien, Jan, et al.
Publicado: (2014) -
Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019) -
Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes
por: Nowak, Natalia, et al.
Publicado: (2016)